Oxidative stress and β -thalassemic erythroid cells behind the molecular defect

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  De Franceschi, Lucia ^a   Bertoldi, Mariarita ^b   Matte, Alessandro ^a   Santos Franco, Sara ^a   Pantaleo, Antonella ^c   Ferru, Emanuela ^d   Turrini, Franco ^d  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITY OF SASSARI   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROID CELLS; GLOBIN CHAINS; MEMBRANE PROTEINS; MICRO-PARTICLES; MOLECULAR DEFECTS; PHOSPHATIDYLSERINE; REACTIVE OXYGEN SPECIES; RED CELLS;

CELL MEMBRANES; CHAINS; CHEMICAL COMPOUNDS; DEFECTS; OXIDATIVE STRESS; PROTEINS;

CYTOLOGY;

ALPHA TOCOPHEROL; COMPLEMENT COMPONENT C3B RECEPTOR; CURCUMIN; DEFERIPRONE; ERYTHROCYTE BAND 3 PROTEIN; GLOBIN; GLUTATHIONE; HEME OXYGENASE 1; HEMOGLOBIN; INITIATION FACTOR 2ALPHA; MALONALDEHYDE; PEROXIREDOXIN 2; POTASSIUM CHLORIDE COTRANSPORTER; REACTIVE OXYGEN METABOLITE;

ANEMIA; BETA THALASSEMIA; CELL SURVIVAL; CYTOSKELETON; ELLIPTOCYTOSIS; ERYTHROCYTE LIFESPAN; ERYTHROCYTE MEMBRANE; ERYTHROID CELL; ERYTHROPOIESIS; HUMAN; LIPID PEROXIDATION; MALARIA; MEMBRANE MICROPARTICLE; NONHUMAN; OXIDATIVE STRESS; PENTOSE PHOSPHATE CYCLE; PHENOTYPE; POTASSIUM DEPLETION; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; RETICULOCYTE COUNT; RETICULOENDOTHELIAL SYSTEM; REVIEW; THALASSEMIA INTERMEDIA; ANIMAL; CELL PROTECTION; ERYTHROCYTE; PATHOLOGY;

ANIMALS; BETA-THALASSEMIA; CYTOPROTECTION; ERYTHROCYTES; ERYTHROID CELLS; HUMANS; MALARIA; OXIDATIVE STRESS;

EID: 84885677914     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/985210     Document Type: Review

References (95)

1. Weatherall D. J., The global problem of genetic disease. Annals of Human Biology 2005 32 2 117 122 (Pubitemid 40995611)
2. Weatherall D. J., Clegg J. B., Inherited haemoglobin disorders: an increasing global health problem. Bulletin of the World Health Organization 2001 79 8 704 712 2-s2.0-0034889014 (Pubitemid 32776838)
3. Modell B., Darlison M., Global epidemiology of haemoglobin disorders and derived service indicators. Bulletin of the World Health Organization 2008 86 6 480 487 2-s2.0-44949128064 10.2471/BLT.06.036673 (Pubitemid 351821761)
4. de Franceschi L., Cappellini M. D., Olivieri O., Thrombosis and sickle cell disease. Seminars in Thrombosis and Hemostasis 2011 37 3 226 236 2-s2.0-79953662398 10.1055/s-0031-1273087
5. Rund D., Rachmilewitz E., Beta-thalassemia. The New England Journal of Medicine 2005 353 11 1135 1146
6. Mannu F., Arese P., Cappellini M. D., Fiorelli G., Cappadoro M., Giribaldi G., Turrini F., Role of hemichrome binding to erythrocyte membrane in the generation of band-3 alterations in β -thalassemia intermedia erythrocytes. Blood 1995 86 5 2014 2020 2-s2.0-0029165258
7. Shinar E., Rachmilewitz E. A., Oxidative denaturation of red blood cells in thalassemia. Seminars in Hematology 1990 27 1 70 82 2-s2.0-0025060810 (Pubitemid 20033164)
8. Repka T., Shalev O., Reddy R., Yuan J., Abrahamov A., Rachmilewitz E. A., Low P. S., Hebbel R. P., Nonrandom association of free iron with membranes of sickle and β-thalassemic erythrocytes. Blood 1993 82 10 3204 3210 2-s2.0-0027429655 (Pubitemid 23334952)
9. Schrier S. L., Mohandas N., Globin-chain specificity of oxidation-induced changes in red blood cell membrane properties. Blood 1992 79 6 1586 1592 2-s2.0-0026563546
10. de Franceschi L., Shalev O., Piga A., Collell M., Olivieri O., Corrocher R., Hebbel R. P., Brugnara C., Deferiprone therapy in homozygous human β -thalassemia removes erythrocyte membrane free iron and reduces KCl cotransport activity. Journal of Laboratory and Clinical Medicine 1999 133 1 64 69 2-s2.0-0032896230 10.1053/lc.1999.v133.a94241 (Pubitemid 29032418)
11. Pantaleo A., Ferru E., Giribaldi G., Mannu F., Carta F., Matte A., de Franceschi L., Turrini F., Oxidized and poorly glycosylated band 3 is selectively phosphorylated by Syk kinase to form large membrane clusters in normal and G6PD-deficient red blood cells. Biochemical Journal 2009 418 2 359 367 2-s2.0-61449112071 10.1042/BJ20081557
12. de Franceschi L., Biondani A., Carta F., PTPepsilon has a critical role in signaling transduction pathways and phosphoprotein network topology in red cells. Proteomics 2008 8 22 4695 4708
13. Scott M. D., van den Berg J. J., Repka T., Effect of excess alpha-hemoglobin chains on cellular and membrane oxidation in model beta-thalassemic erythrocytes. Journal of Clinical Investigation 1993 91 4 1706 1712 (Pubitemid 23127376)
14. de Franceschi L., Tomelleri C., Matte A., Brunati A. M., Bovee-Geurts P. H., Bertoldi M., Lasonder E., Tibaldi E., Danek A., Walker R. H., Jung H. H., Bader B., Siciliano A., Ferru E., Mohandas N., Bosman G. J. C. G. M., Erythrocyte membrane changes of chorea-acanthocytosis are the result of altered Lyn kinase activity. Blood 2011 118 20 5652 5663 2-s2.0-81555195727 10.1182/blood-2011-05-355339
15. Shinar E., Rachmilewitz E. A., Lux S. E., Differing erythrocyte membrane skeletal protein defects in alpha and beta thalassemia. Journal of Clinical Investigation 1989 83 2 404 410 2-s2.0-0024560085 (Pubitemid 19061158)
16. Pantaleo A., de Franceschi L., Ferru E., Vono R., Turrini F., Current knowledge about the functional roles of phosphorylative changes of membrane proteins in normal and diseased red cells. Journal of Proteomics 2010 73 3 445 455 2-s2.0-72149101507 10.1016/j.jprot.2009.08.011
17. Siciliano A., Turrini F., Bertoldi M., Matte A., Pantaleo A., Olivieri O., de Franceschi L., Deoxygenation affects tyrosine phosphoproteome of red cell membrane from patients with sickle cell disease. Blood Cells, Molecules, and Diseases 2010 44 4 233 242 2-s2.0-77950299188 10.1016/j.bcmd.2010.02.007
18. Iolascon A., De Falco L., Borgese F., Esposito M. R., Avvisati R. A., Izzo P., Piscopo C., Guizouarn H., Biondani A., Pantaleo A., de Franceschi L., A novel erythroid anion exchange variant (Gly796Arg) of hereditary stomatocytosis associated with dyserythropoiesis. Haematologica 2009 94 8 1049 1059 2-s2.0-68049142292 10.3324/haematol.2008.002873
19. Mohandas N., An X., New insights into function of red cell membrane proteins and their interaction with spectrin-based membrane skeleton. Transfusion Clinique et Biologique 2006 13 1-2 29 30 2-s2.0-33646017711 10.1016/j.tracli.2006.02.017
20. Ferru E., Giger K., Pantaleo A., Campanella E., Grey J., Ritchie K., Vono R., Turrini F., Low P. S., Regulation of membrane-cytoskeletal interactions by tyrosine phosphorylation of erythrocyte band 3. Blood 2011 117 22 5998 6006 2-s2.0-79958002789 10.1182/blood-2010-11-317024
21. Westerman M., Pizzey A., Hirschman J., Cerino M., Weil-Weiner Y., Ramotar P., Eze A., Lawrie A., Purdy G., Mackie I., Porter J., Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy. The British Journal of Haematology 2008 142 1 126 135 2-s2.0-44649183571 10.1111/j.1365-2141.2008.07155.x (Pubitemid 351783151)
22. Hahalis G., Kalogeropoulos A., Terzis G., Tselepis A. D., Kourakli A., Mylona P., Grapsas N., Alexopoulos D., Premature atherosclerosis in non-transfusion-dependent β -thalassemia intermedia. Cardiology 2011 118 3 159 163 2-s2.0-79957863697 10.1159/000327997
23. Harrison M. L., Rathinavelu P., Arese P., Geahlen R. L., Low P. S., Role of band 3 tyrosine phosphorylation in the regulation of erythrocyte glycolysis. Journal of Biological Chemistry 1991 266 7 4106 4111 2-s2.0-0025859158 (Pubitemid 21909326)
24. Cappellini M. D., Tavazzi D., Duca L., Graziadei G., Mannu F., Turrini F., Arese P., Fiorelli G., Metabolic indicators of oxidative stress correlate with haemichrome attachment to membrane, band 3 aggregation and erythrophagocytosis in β-thalassaemia intermedia. The British Journal of Haematology 1999 104 3 504 512 2-s2.0-0033057033 (Pubitemid 29119274)
25. Low P. S., Structure and function of the cytoplasmic domain of band 3: center of erythrocyte membrane-peripheral protein interactions. Biochimica et Biophysica Acta 1986 864 2 145 167 2-s2.0-0022922389 (Pubitemid 16027843)
26. Tokumasu F., Fairhurst R. M., Ostera G. R., Brittain N. J., Hwang J., Wellems T. E., Dvorak J. A., Band 3 modifications in Plasmodium falciparum-infected AA and CC erythrocytes assayed by autocorrelation analysis using quantum dots. Journal of Cell Science 2005 118 5 1091 1098 2-s2.0-16844378031 10.1242/jcs.01662 (Pubitemid 40484897)
27. +- thalassaemia contributes to protection against severe malarial anaemia. PLoS Medicine 2008 5 3, article e56 0494 0501 2-s2.0-41549115445 10.1371/journal. pmed.0050056 (Pubitemid 351471698)
28. López C., Saravia C., Gomez A., Hoebeke J., Patarroyo M. A., Mechanisms of genetically-based resistance to malaria. Gene 2010 467 1-2 1 12 2-s2.0-77956880216 10.1016/j.gene.2010.07.008
29. Williams T. N., Maitland K., Bennett S., Ganczakowski M., Peto T. E. A., Newbold C. I., Bowden D. K., Weatherall D. J., Clegg J. B., High incidence of malaria in α -thalassaemic children. Nature 1996 383 6600 522 525 2-s2.0-0029858255 10.1038/383522a0 (Pubitemid 26346177)
30. Allen S. J., 'Donnell A O., Alexander N. D., alpha+-Thalassemia protects children against disease caused by other infections as well as malaria. Proceedings of the National Academy of Sciences of the United States of America 1997 94 26 14736 14741 (Pubitemid 28041443)
31. +-thalassemia protects African children from severe malaria. Blood 2004 104 7 2003 2006 2-s2.0-4644337767 10.1182/blood-2003-11-4090 (Pubitemid 39297850)
32. +-thalassaemia on the incidence of malaria and other diseases in children living on the coast of Kenya. PLoS Medicine 2006 3 5, article e158 2-s2.0-33744459954 10.1371/journal.pmed.0030158 (Pubitemid 43807033)
33. Enevold A., Lusingu J. P., Mmbando B., Alifrangis M., Lemnge M. M., Bygbjerg I. C., Theander T. G., Vestergaard L. S., Reduced risk of uncomplicated malaria episodes in children with alpha +-thalassemia in Northeastern Tanzania. The American Journal of Tropical Medicine and Hygiene 2008 78 5 714 720 2-s2.0-45049087688 (Pubitemid 351845125)
34. Luzzi G. A., Merry A. H., Newbold C. I., Marsh K., Pasvol G., Protection by α -thalassaemia against Plasmodium falciparum malaria: modified surface antigen expression rather than impaired growth or cytoadherence. Immunology Letters 1991 30 2 233 240 2-s2.0-0026095859 10.1016/0165-2478(91)90031-5
35. Yuthavong Y., Wilairat P., Protection against malaria by thalassaemia and haemoglobin variants. Parasitology Today 1993 9 7 241 245 2-s2.0-0027264908 10.1016/0169-4758(93)90065-N (Pubitemid 23171450)
36. Cockburn I. A., Mackinnon M. J., O'Donnell A., Allen S. J., Moulds J. M., Baisor M., Bockarie M., Reeder J. C., Rowe J. A., A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria. Proceedings of the National Academy of Sciences of the United States of America 2004 101 1 272 277 2-s2.0-0345827588 10.1073/pnas.0305306101 (Pubitemid 38084240)
37. Willcox M., Bjorkman A., Brohult J., Falciparum malaria and β -thalassaemia trait in northern Liberia. Annals of Tropical Medicine and Parasitology 1983 77 4 335 347 2-s2.0-0020637632 (Pubitemid 13002407)
38. Brockelman C. R., Wongsattayanont B., Tan-Ariya P., Fucharoen S., Thalassemic erythrocytes inhibit in vitro growth of Plasmodium falciparum. Journal of Clinical Microbiology 1987 25 1 56 60 2-s2.0-0023230186 (Pubitemid 17202974)
39. Smith T. G., Ayi K., Serghides L., Mcallister C. D., Kain K. C., Innate immunity to malaria caused by Plasmodium falciparum. Clinical and Investigative Medicine 2002 25 6 262 272 2-s2.0-0036992329 (Pubitemid 36197497)
40. Ayi K., Turrini F., Piga A., Arese P., Enhanced phagocytosis of ring-parasitized mutant erythrocytes: a common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait. Blood 2004 104 10 3364 3371 2-s2.0-8644226200 10.1182/blood-2003-11-3820 (Pubitemid 39507160)
41. Perrotta S., Borriello A., Scaloni A., de Franceschi L., Brunati A. M., Turrini F., Nigro V., Miraglia Del Giudice E., Nobili B., Conte M. L., Rossi F., Iolascon A., Donella-Deana A., Zappia V., Poggi V., Anong W., Low P., Mohandas N., Della Ragione F., The N-terminal 11 amino acids of human erythrocyte band 3 are critical for aldolase binding and protein phosphorylation: implications for band 3 function. Blood 2005 106 13 4359 4366 2-s2.0-28844493639 10.1182/blood-2005-07-2806 (Pubitemid 41775948)
42. Genton B., Al-Yaman F., Mgone C. S., Alexander N., Paniu M. M., Alpers M. P., Mokela D., Ovalocytosis and cerebral malaria. Nature 1995 378 6557 564 565 2-s2.0-0028810385
43. Allen S. J., O'Donnell A., Alexander N. D. E., Mgone C. S., Peto T. E. A., Clegg J. B., Alpers M. P., Weatherall D. J., Prevention of cerebral malaria in children in Papua New Guinea by Southeast Asian ovalocytosis band 3. The American Journal of Tropical Medicine and Hygiene 1999 60 6 1056 1060 2-s2.0-0033024133 (Pubitemid 29296237)
44. Williams T. N., Red blood cell defects and malaria. Molecular and Biochemical Parasitology 2006 149 2 121 127 2-s2.0-33747803083 10.1016/j.molbiopara.2006.05.007 (Pubitemid 44279089)
45. Murray M. C., Perkins M. E., Phosphorylation of erythrocyte membrane and cytoskeleton proteins in cells infected with Plasmodium falciparum. Molecular and Biochemical Parasitology 1989 34 3 229 236 2-s2.0-0024521681 (Pubitemid 19119808)
46. Magowan C., Liang J., Yeung J., Takakuwa Y., Coppel R. L., Mohandas N., Plasmodium falciparum: influence of malarial and host erythrocyte skeletal protein interactions on phosphorylation in infected erythrocytes. Experimental Parasitology 1998 89 1 40 49 2-s2.0-0032077664 10.1006/expr.1998.4261 (Pubitemid 28377371)
47. Suetterlin B. W., Kappes B., Franklin R. M., Localization and stage specific phosphorylation of Plasmodium falciparum phosphoproteins during the intraerythrocytic cycle. Molecular and Biochemical Parasitology 1991 46 1 113 122 2-s2.0-0025971117 10.1016/0166-6851(91)90205-K
48. Pantaleo A., Ferru E., Carta F., Mannu F., Giribaldi G., Vono R., Lepedda A. J., Pippia P., Turrini F., Analysis of changes in tyrosine and serine phosphorylation of red cell membrane proteins induced by P. falciparum growth. Proteomics 2010 10 19 3469 3479 2-s2.0-77957201329 10.1002/pmic.201000269
49. Pantaleo A., Ferru E., Vono R., Giribaldi G., Lobina O., Nepveu F., Ibrahim H., Nallet J.-P., Carta F., Mannu F., Pippia P., Campanella E., Low P. S., Turrini F., New antimalarial indolone-N-oxides, generating radical species, destabilize the host cell membrane at early stages of Plasmodium falciparum growth: role of band 3 tyrosine phosphorylation. Free Radical Biology and Medicine 2012 52 2 527 536 2-s2.0-84855421538 10.1016/j.freeradbiomed.2011.11. 008
50. Pantaleo A., Giribaldi G., Mannu F., Arese P., Turrini F., Naturally occurring anti-band 3 antibodies and red blood cell removal under physiological and pathological conditions. Autoimmunity Reviews 2008 7 6 457 462 2-s2.0-51749087913 10.1016/j.autrev.2008.03.017
51. Olivieri O., de Franceschi L., Capellini M. D., Girelli D., Corrocher R., Brugnara C., Oxidative damage and erythrocyte membrane transport abnormalities in thalassemias. Blood 1994 84 1 315 320 2-s2.0-0028282433 (Pubitemid 24193836)
52. de Franceschi L., Ronzoni L., Cappellini M. D., Cimmino F., Siciliano A., Alper S. L., Servedio V., Pozzobon C., Iolascon A., K-CL co-transport plays an important role in normal and β thalassemic erythropoiesis. Haematologica 2007 92 10 1319 1326 2-s2.0-36348943529 10.3324/haematol.11556 (Pubitemid 350144149)
53. Brugnara C., de Franceschi L., Effect of cell age and phenylhydrazine on the cation transport properties of rabbit erythrocytes. Journal of Cellular Physiology 1993 154 2 271 280 2-s2.0-0027406483 10.1002/jcp.1041540209 (Pubitemid 23048007)
54. Su W., Shmukler B. E., Chernova M. N., Stuart-Tilley A. K., de Franceschi L., Brugnara C., Alper S. L., Mouse K-Cl cotransporter KCC1: cloning, mapping, pathological expression, and functional regulation. The American Journal of Physiology 1999 277 5 C899 C912 2-s2.0-0032759118
55. de Franceschi L., Turrini F., del Giudice E. M., Perrotta S., Olivieri O., Corrocher R., Mannu F., Iolascon A., Decreased band 3 anion transport activity and band 3 clusterization in congenital dyserythropoietic anemia type II. Experimental Hematology 1998 26 9 869 873 2-s2.0-0031876029 (Pubitemid 28350758)
56. de Franceschi L., Olivieri O., Miraglia del Giudice E., Membrane cation and anion transport activities in erythrocytes of hereditary spherocytosis: effects of different membrane protein defects. American Journal of Hematology 1997 55 3 121 128 (Pubitemid 27333333)
57. de Franceschi L., Franco R. S., Bertoldi M., Pharmacological inhibition of calpain-1 prevents red cell dehydration and reduces Gardos channel activity in a mouse model of sickle cell disease. FASEB Journal 2013 27 2 750 759
58. 2+-activated K+ transport and reverses erythrocyte dehydration in transgenic SAD mice. A model for therapy of sickle cell disease. Journal of Clinical Investigation 1994 93 4 1670 1676 2-s2.0-0028316266
59. Wieschhaus A., Khan A., Zaidi A., Calpain-1 knockout reveals broad effects on erythrocyte deformability and physiology. The Biochemical Journal 2012 448 1 141 152
60. de Franceschi L., Fumagalli L., Olivieri O., Corrocher R., Lowell C. A., Berton G., Deficiency of Src family kinases Fgr and Hck results in activation of erythrocyte K/Cl cotransport. Journal of Clinical Investigation 1997 99 2 220 227 2-s2.0-0031030067 (Pubitemid 27060715)
61. de Franceschi L., Dietary magnesium supplementation reduces pain crises in patients with sickle cell disease. Blood 1997 90
62. de Franceschi L., Rouyer-Fessard P., Alper S. L., Jouault H., Brugnara C., Beuzard Y., Combination therapy of erythropoietin, hydroxyurea, and clotrimazole in a β thalassemic mouse: a model for human therapy. Blood 1996 87 3 1188 1195 2-s2.0-0030063536 (Pubitemid 26043548)
63. de Franceschi L., Cappellini M. D., Graziadei G., Manzato F., Olivieri O., Corrocher R., Fiorelli G., Beuzard Y., Brugnara C., The effect of dietary magnesium supplementation on the cellular abnormalities of erythrocytes in patients with β thalassemia intermedia. Haematologica 1998 83 2 118 125 2-s2.0-0031942265 (Pubitemid 28180605)
64. de Franceschi L., Brugnara C., Beuzard Y., Dietary magnesium supplementation ameliorates anemia in a mouse model of β -thalassemia. Blood 1997 90 3 1283 1290 2-s2.0-0030795632 (Pubitemid 27314167)
65. de Franceschi L., Daraio F., Filippini A., Carturan S., Muchitsch E. M., Roetto A., Camaschella C., Liver expression of hepcidin and other iron genes in two mouse models of β -thalassemia. Haematologica 2006 91 10 1336 1342 2-s2.0-33750033613 (Pubitemid 44569806)
66. de Franceschi L., Turrini F., Honczarenko M., In vivo reduction of erythrocyte oxidant stress in a murine model of beta-thalassemia. Haematologica 2004 89 11 1287 1298 (Pubitemid 39540565)
67. Shalev O., Repka T., Goldfarb A., Grinberg L., Abrahamov A., Olivieri N. F., Rachmilewitz E. A., Hebbel R. P., Deferiprone (L1) chelates pathologic iron deposits from membranes of intact thalassemic and sickle red blood cells both in vitro and in vivo. Blood 1995 86 5 2008 2013 2-s2.0-0029097965
68. Hyman C. B., Ortega J. A., Costin G., Takahashi M., The clinical significance of magnesium depletion in thalassemia. Annals of the New York Academy of Sciences 1980 344 436 443 (Pubitemid 11140753)
69. Abbasciano V., Bader G., Graziano L., Mazzotta D., Vecchiatti G., Guglielmini C., Sartori S., Serum and erythrocyte levels of magnesium in microcytosis: comparison between heterozygous beta-thalassemia and sideropenic anemia. Haematologica 1991 76 4 339 341 2-s2.0-0026072083
70. Rachmilewitz E. A., Shifter A., Kahane I., Vitamin E deficiency in β -thalassemia major: changes in hematological and biochemical parameters after a therapeutic trial with α -tocopherol. The American Journal of Clinical Nutrition 1979 32 9 1850 1858 2-s2.0-0018728292 (Pubitemid 10220297)
71. Kahane I., Rachmilewitz E. A., Alterations in the red blood cell membrane and the effect of vitamin E on osmotic fragility in β thalassemia major. Israel Journal of Medical Sciences 1976 12 1 11 15 2-s2.0-0017256126
72. Tesoriere L., D'Arpa D., Butera D., Allegra M., Renda D., Maggio A., Bongiorno A., Livrea M. A., Oral supplements of vitamin E improve measures of oxidative stress in plasma and reduce oxidative damage to LDL and erythrocytes in β -thalassemia intermedia patients. Free Radical Research 2001 34 5 529 540 2-s2.0-0035007589 (Pubitemid 32492691)
73. Fibach E., Rachmilewitz E. A., The role of antioxidants and iron chelators in the treatment of oxidative stress in thalassemia. Annals of the New York Academy of Sciences 2010 1202 10 16 2-s2.0-77955905915 10.1111/j.1749-6632.2010.05577.x
74. Srichairatanakool S., Thephinlap C., Phisalaphong C., Porter J. B., Fucharoen S., Curcumin contributes to in vitro removal of non-transferrin bound iron by deferiprone and desferrioxamine in thalassemic plasma. Medicinal Chemistry 2007 3 5 469 474 2-s2.0-34648819489 10.2174/157340607781745447 (Pubitemid 47455737)
75. Amer J., Atlas D., Fibach E., N-acetylcysteine amide (AD4) attenuates oxidative stress in beta-thalassemia blood cells. Biochimica et Biophysica Acta 2008 1780 2 249 255 2-s2.0-38549144785 10.1016/j.bbagen.2007.11.009
76. Amer J., Goldfarb A., Rachmilewitz E. A., Fibach E., Fermented papaya preparation as redox regulator in blood cells of β -thalassemic mice and patients. Phytotherapy Research 2008 22 6 820 828 2-s2.0-46849096278 10.1002/ptr.2379 (Pubitemid 351955583)
77. Weiss L., A rationale for an individualized administration frequency of epoetin β: a clinical perspective. Nephrology Dialysis Transplantation 2002 17 supplement 6 8 12 2-s2.0-0036325265 (Pubitemid 34823543)
78. Lai M. I., Jiang J., Silver N., Alpha-haemoglobin stabilising protein is a quantitative trait gene that modifies the phenotype of beta-thalassaemia. The British Journal of Haematology 2006 133 6 675 682 (Pubitemid 43742786)
79. Yu X., Kong Y., Dore L. C., An erythroid chaperone that facilitates folding of alpha-globin subunits for hemoglobin synthesis. The Journal of Clinical Investigation 2007 117 7 1856 1865 (Pubitemid 47036319)
80. Khandros E., Mollan T. L., Yu X., Wang X., Yao Y., D'Souza J., Gell D. A., Olson J. S., Weiss M. J., Insights into hemoglobin assembly through in vivo mutagenesis of α -hemoglobin stabilizing protein. Journal of Biological Chemistry 2012 287 14 11325 11337 2-s2.0-84859507078 10.1074/jbc.M111.313205
81. Chen J. J., Regulation of protein synthesis by the heme-regulated eIF2alpha kinase: relevance to anemias. Blood 2007 109 7 2693 2699
82. Lu L., Han A.-P., Chen J.-J., Translation initiation control by heme-regulated eukaryotic initiation factor 2 α kinase in erythroid cells under cytoplasmic stresses. Molecular and Cellular Biology 2001 21 23 7971 7980 2-s2.0-0035166679 10.1128/MCB.21.23.7971-7980.2001 (Pubitemid 33051789)
83. Han A.-P., Yu C., Lu L., Fujiwara Y., Browne C., Chin G., Fleming M., Leboulch P., Orkin S. H., Chen J.-J., Heme-regulated eIF2 α kinase (HRI) is required for translational regulation and survival of erythroid precursors in iron deficiency. EMBO Journal 2001 20 23 6909 6918 2-s2.0-17944362905 10.1093/emboj/20.23.6909 (Pubitemid 33134220)
84. Suragani R. N., Zachariah R. S., Velazquez J. G., Heme-regulated eIF2alpha kinase activated Atf4 signaling pathway in oxidative stress and erythropoiesis. Blood 2012 119 22 5276 5284
85. Jang H. H., Lee K. O., Chi Y. H., Jung B. G., Park S. K., Park J. H., Lee J. R., Lee S. S., Moon J. C., Yun J. W., Choi Y. O., Kim W. Y., Kang J. S., Cheong G.-W., Yun D.-J., Rhee S. G., Cho M. J., Lee S. Y., Two enzymes in one: two yeast peroxiredoxins display oxidative stress-dependent switching from a peroxidase to a molecular chaperone function. Cell 2004 117 5 625 635 2-s2.0-2542464938 10.1016/j.cell.2004.05.002 (Pubitemid 38692528)
86. Wood Z. A., Schröder E., Harris J. R., Poole L. B., Structure, mechanism and regulation of peroxiredoxins. Trends in Biochemical Sciences 2003 28 1 32 40 2-s2.0-0037222255 10.1016/S0968-0004(02)00003-8 (Pubitemid 36051004)
87. Low F. M., Hampton M. B., Winterbourn C. C., Peroxiredoxin 2 and peroxide metabolism in the erythrocyte. Antioxidants and Redox Signaling 2008 10 9 1621 1630 2-s2.0-46449103811 10.1089/ars.2008.2081 (Pubitemid 351931937)
88. Manta B., Hugo M., Ortiz C., Ferrer-Sueta G., Trujillo M., Denicola A., The peroxidase and peroxynitrite reductase activity of human erythrocyte peroxiredoxin 2. Archives of Biochemistry and Biophysics 2009 484 2 146 154 2-s2.0-64749114296 10.1016/j.abb.2008.11.017
89. Matte A., Low P. S., Turrini F., Bertoldi M., Campanella M. E., Spano D., Pantaleo A., Siciliano A., de Franceschi L., Peroxiredoxin-2 expression is increased in β -thalassemic mouse red cells but is displaced from the membrane as a marker of oxidative stress. Free Radical Biology and Medicine 2010 49 3 457 466 2-s2.0-77954144286 10.1016/j.freeradbiomed.2010.05.003
90. Matte A., Bertoldi M., Mohandas N., Membrane association of peroxiredoxin-2 in red cells is mediated by the N-terminal cytoplasmic domain of band 3. Free Radical Biology and Medicine 2013 55 27 35
91. de Franceschi L., Bertoldi M., de Falco L., Franco S. S., Ronzoni L., Turrini F., Colancecco A., Camaschella C., Cappellini M. D., Iolascon A., Oxidative stress modulates heme synthesis and induces peroxiredoxin-2 as a novel cytoprotective response in β -thalassemic erythropoiesis. Haematologica 2011 96 11 1595 1604 2-s2.0-80355127340 10.3324/haematol.2011.043612
92. Zhang P., Liu B., Kang S. W., Seo M. S., Rhee S. G., Obeid L. M., Thioredoxin peroxidase is a novel inhibitor of apoptosis with a mechanism distinct from that of Bcl-2. Journal of Biological Chemistry 1997 272 49 30615 30618 2-s2.0-0030692005 10.1074/jbc.272.49.30615 (Pubitemid 27527491)
93. Kang S. W., Chae H. Z., Seo M. S., Kim K., Baines I. C., Rhee S. G., Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generatedin response to growth factors and tumor necrosis factor- α Journal of Biological Chemistry 1998 273 11 6297 6302 2-s2.0-0141746553 10.1074/jbc.273.11.6297 (Pubitemid 28144719)
94. Liu J., Zhang J., Ginzburg Y., Quantitative analysis of murine terminal erythroid differentiation in vivo: novel method to study normal and disordered erythropoiesis. Blood 2013 121 2 e43 e49
95. 3 and ameliorates anemia in beta-thalassemic mice. Haematologica 2013 10.3324/haematol.2013.090076